Stock Analysts’ new coverage for Wednesday, December 17th:
Evercore ISI initiated coverage on shares of Grupo Aeromexico (NYSE:AERO). Evercore ISI issued an outperform rating and a $36.00 price target on the stock.
Canaccord Genuity Group Inc. assumed coverage on shares of Alterity Therapeutics (NASDAQ:ATHE). They issued a speculative buy rating on the stock.
JPMorgan Chase & Co. started coverage on shares of Eos Energy Enterprises (NASDAQ:EOSE). The firm issued a neutral rating and a $16.00 target price on the stock.
Citigroup Inc. began coverage on shares of Amicus Therapeutics (NASDAQ:FOLD). The firm issued a buy rating and a $17.00 price target on the stock.
BTIG Research started coverage on shares of ZoomInfo Technologies (NASDAQ:GTM). They issued a buy rating and a $13.00 target price on the stock.
JPMorgan Chase & Co. began coverage on shares of Garrett Motion (NYSE:GTX). They issued an overweight rating and a $23.00 price target on the stock.
Truist Financial Corporation started coverage on shares of Robinhood Markets (NASDAQ:HOOD). Truist Financial Corporation issued a buy rating and a $155.00 price target on the stock.
Barclays PLC initiated coverage on shares of Independent Bank (NASDAQ:INDB). They issued an equal weight rating and a $80.00 price target on the stock.
JPMorgan Chase & Co. began coverage on shares of PACS Group (NYSE:PACS). The firm issued an overweight rating and a $44.00 price target on the stock.
BTIG Research assumed coverage on shares of Paycom Software (NYSE:PAYC). BTIG Research issued a buy rating and a $195.00 target price on the stock.
Royal Bank Of Canada began coverage on shares of Koninklijke Philips (NYSE:PHG). They issued a sector perform rating on the stock.
Citizens Jmp started coverage on shares of Spotify Technology (NYSE:SPOT). The firm issued a market outperform rating and a $800.00 target price on the stock.
TD Cowen started coverage on shares of Vor Biopharma (NASDAQ:VOR). The firm issued a buy rating on the stock.
Truist Financial Corporation initiated coverage on shares of Zymeworks (NYSE:ZYME). The firm issued a buy rating and a $40.00 price target on the stock.
Receive News & Ratings for Grupo Aeromexico Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grupo Aeromexico and related companies with MarketBeat.com's FREE daily email newsletter.
